化学
前药
荧光
光动力疗法
和厚朴酚
体内
过氧亚硝酸盐
药品
萘普生
生物物理学
结合
荧光团
体外
共焦显微镜
药理学
荧光显微镜
药物输送
吖啶衍生物
生物化学
光毒性
组合化学
共焦
荧光标记
活性氮物种
紧身衣
单线态氧
姜黄素
荧光寿命成像显微镜
内吞作用
作者
R. A. Aswini,Abhijit Karmakar,Astha Katiyar,Apurba Lal Koner
标识
DOI:10.1021/acs.analchem.6c04334
摘要
Stimuli-responsive prodrugs that combine therapeutic efficacy with optical reporting offer promising avenues for precision medicine. This study presents a dicyanoisophorone-naproxen (DCIP-Nap) conjugate, which merges the anti-inflammatory effects of naproxen with a donor-π-acceptor fluorescent scaffold. Initially, the conjugate is nonfluorescent due to suppressed intramolecular charge transfer. However, it shows a notable fluorescence "turn-on" response upon ester bond cleavage, facilitated by serum albumin. This selective release of active naproxen also restores the ICT process, resulting in a red-shifted emission. The probe further exhibits selective responsiveness toward peroxynitrite (ONOO-), a reactive nitrogen species abundantly generated in inflamed cells. Confocal microscopy using human glioblastoma (U-87 MG) and human leukemia monocytic (THP-1) cells demonstrated increased fluorescence intensity under inflammatory conditions, confirming ONOO--mediated drug release. In vivo studies in LPS-treated mice showed fluorescence activation and decreased pro-inflammatory cytokines (TNF-α and IL-6), highlighting the therapeutic potential of DCIP-Nap. This study positions DCIP-Nap as an innovative fluorescent prodrug for targeted therapy and real-time monitoring in complex diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI